COVID-19 VACCINE DEVELOPMENT UPDATES


WHO Public statement for collaboration on COVID-19 vaccine development.

We are scientists, physicians, funders and manufacturers who have come together as part of an international collaboration, coordinated by the World Health Organization (WHO), to help speed the availability of a vaccine against COVID-19. While a vaccine for general use takes time to develop, a vaccine may ultimately be instrumental in controlling this worldwide pandemic. In the interim, we applaud the implementation of community intervention measures that reduce spread of the virus and protect people, including vulnerable populations, and pledge to use the time gained by the widespread adoption of such measures to develop a vaccine as rapidly as possible. We will continue efforts to strengthen the unprecedented worldwide collaboration, cooperation and sharing of data already underway. We believe these efforts will help reduce inefficiencies and duplication of effort, and we will work tenaciously to increase the likelihood that one or more safe and effective vaccines will soon be made available to all.

EiP Institute logo

WHO: Draft landscape of COVID-19 candidate vaccines

May 27, 2020

These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning 2019-2020 global of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all) representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss, damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of these landscape documents. 


(25 MARCH 2020) ECDC RAPID RISK ASSESSMENT COVID-19

As of 25 March 2020, more than 416 916 cases of COVID-19 were reported worldwide by more than 150 countries. An increasing proportion of global cases are from EU/EEA countries and the UK. As of 25 March, 204 930 cases and 11 810 deaths have been reported in the EU/EEA and the UK. 

Read more

ECDC: EUROSURVEILLANCE LATEST JOURNAL ARTICLES ON COVID-19.

Europe's journal on infectious disease surveillance, epidemiology, prevention and control aims to provide timely facts and guidance for public health professionals and decision-makers in the field of infectious disease to facilitate the implementation of effective prevention and control measures. Access the latest journal articles on COVID-19.

Read more

SANOFI MOBILIZES TO DEVELOP A VACCINE AGAINST COVID-19

John Shiver, PhD, Senior Vice President, Vaccines Global R&D at Sanofi, discusses the mechanics of developing a vaccine in response to a pandemic and why he believes it can be done in time to stop the spread of COVID-19.

Read more

get updates

connect